tetano
Editor, Senior Moderator
PLoS One. 2018 Jun 27;13(6):e0199683. doi: 10.1371/journal.pone.0199683. eCollection 2018.
[h=1]Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.[/h] Trost JF[SUP]1,[/SUP][SUP]2[/SUP], LeMasters EH[SUP]1[/SUP], Liu F[SUP]1[/SUP], Carney P[SUP]1[/SUP], Lu X[SUP]1[/SUP], Sugawara K[SUP]3[/SUP], Hongo S[SUP]3[/SUP], Stevens J[SUP]1[/SUP], Steinhauer DA[SUP]2[/SUP], Tumpey T[SUP]1[/SUP], Katz JM[SUP]1[/SUP], Levine MZ[SUP]1[/SUP], Li ZN[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Many broadly neutralizing antibodies (bnAbs) bind to conserved areas of the hemagglutinin (HA) stalk region and can inhibit the low pH induced HA conformational changes necessary for viral membrane fusion activity. We developed and evaluated a high-throughput virus-free and cell-free ELISA based low pH induced HA Conformational Change Inhibition Antibody Detection Assay (HCCIA) and a complementary proteinase susceptibility assay. Human serum samples (n = 150) were tested by HCCIA using H3 recombinant HA. Optical density (OD) ratios of mAb HC31 at pH 4.8 to pH 7.0 ranged from 0.87 to 0.09. Our results demonstrated that low pH induced HA conformational change inhibition antibodies (CCI) neutralized multiple H3 strains after removal of head-binding antibodies. The results suggest that HCCIA can be utilized to detect and characterize CCI in sera, that are potentially broadly neutralizing, and serves as a useful tool for evaluating universal vaccine candidates targeting the HA stalk.
PMID: 29949635 DOI: 10.1371/journal.pone.0199683
[h=1]Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.[/h] Trost JF[SUP]1,[/SUP][SUP]2[/SUP], LeMasters EH[SUP]1[/SUP], Liu F[SUP]1[/SUP], Carney P[SUP]1[/SUP], Lu X[SUP]1[/SUP], Sugawara K[SUP]3[/SUP], Hongo S[SUP]3[/SUP], Stevens J[SUP]1[/SUP], Steinhauer DA[SUP]2[/SUP], Tumpey T[SUP]1[/SUP], Katz JM[SUP]1[/SUP], Levine MZ[SUP]1[/SUP], Li ZN[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Many broadly neutralizing antibodies (bnAbs) bind to conserved areas of the hemagglutinin (HA) stalk region and can inhibit the low pH induced HA conformational changes necessary for viral membrane fusion activity. We developed and evaluated a high-throughput virus-free and cell-free ELISA based low pH induced HA Conformational Change Inhibition Antibody Detection Assay (HCCIA) and a complementary proteinase susceptibility assay. Human serum samples (n = 150) were tested by HCCIA using H3 recombinant HA. Optical density (OD) ratios of mAb HC31 at pH 4.8 to pH 7.0 ranged from 0.87 to 0.09. Our results demonstrated that low pH induced HA conformational change inhibition antibodies (CCI) neutralized multiple H3 strains after removal of head-binding antibodies. The results suggest that HCCIA can be utilized to detect and characterize CCI in sera, that are potentially broadly neutralizing, and serves as a useful tool for evaluating universal vaccine candidates targeting the HA stalk.
PMID: 29949635 DOI: 10.1371/journal.pone.0199683